ContraVir Strengthens Its Board Of Directors With The Addition Of Virology Expert, Scientist, And Entrepreneur, Timothy M. Block, Ph.D.
4/23/2014 7:22:34 AM
ContraVir Pharmaceuticals, Inc. (OTCBB:CTRV), an emerging biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that Timothy M. Block, Ph.D. has joined the company’s Board of Directors. A renowned researcher and opinion leader in the field of virology, Dr. Block is a professor and founder of the Hepatitis B Foundation. His scientific work centers on the study and treatment of chronic viral infections including hepatitis B and C, and herpes simplex virus. Dr. Block has invented or co-invented several compounds designed to treat liver cancer and viral infection.
Help employers find you! Check out all the jobs and post your resume.
comments powered by